Raymond James Financial Services Advisors Inc. Sells 2,046 Shares of Smith & Nephew plc (NYSE:SNN)

Raymond James Financial Services Advisors Inc. reduced its stake in shares of Smith & Nephew plc (NYSE:SNN) by 9.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 18,842 shares of the medical equipment provider’s stock after selling 2,046 shares during the quarter. Raymond James Financial Services Advisors Inc.’s holdings in Smith & Nephew were worth $514,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of the stock. FNY Investment Advisers LLC acquired a new stake in shares of Smith & Nephew during the 4th quarter worth $272,000. Scharf Investments LLC grew its holdings in shares of Smith & Nephew by 20.5% during the 4th quarter. Scharf Investments LLC now owns 2,980,334 shares of the medical equipment provider’s stock worth $81,304,000 after purchasing an additional 506,474 shares in the last quarter. BKM Wealth Management LLC acquired a new stake in shares of Smith & Nephew during the 4th quarter worth $422,000. First Hawaiian Bank grew its holdings in shares of Smith & Nephew by 15.0% during the 4th quarter. First Hawaiian Bank now owns 11,250 shares of the medical equipment provider’s stock worth $307,000 after purchasing an additional 1,466 shares in the last quarter. Finally, American Century Companies Inc. grew its holdings in shares of Smith & Nephew by 343.5% during the 3rd quarter. American Century Companies Inc. now owns 2,364,037 shares of the medical equipment provider’s stock worth $58,557,000 after purchasing an additional 1,830,965 shares in the last quarter. 25.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised Smith & Nephew from a “buy” rating to a “strong-buy” rating in a research note on Friday, March 15th. Three research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Smith & Nephew has a consensus rating of “Moderate Buy”.

Smith & Nephew Stock Down 0.7 %

NYSE:SNN opened at $23.84 on Friday. The stock’s 50-day simple moving average is $26.33 and its 200 day simple moving average is $25.94. The company has a quick ratio of 0.72, a current ratio of 1.77 and a debt-to-equity ratio of 0.44. Smith & Nephew plc has a twelve month low of $21.52 and a twelve month high of $33.08.

Smith & Nephew Announces Dividend

The firm also recently disclosed a semi-annual dividend, which will be paid on Wednesday, May 22nd. Investors of record on Tuesday, April 2nd will be paid a $0.462 dividend. This represents a yield of 2.8%. The ex-dividend date of this dividend is Monday, April 1st.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.